HLB Co., Ltd.
028300
Classifica tra le azioni
#4131
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Prezzo delle azioni
$29.60
Capitalizzazione di mercato
$3.93B
Variazione (1 giorno)
-0.35%
Variazione (1 anno)
-7.48%
Paese
KR
Scambia HLB Co., Ltd. (028300)
Categoria
Healthcare
Utile per HLB Co., Ltd. (028300)
Utile nel Jun 2026 TTM: $-160.32M
Secondo gli ultimi rapporti finanziari di HLB Co., Ltd., gli utili attuali della società sono $-160.32M. Nel 2023, la società ha registrato un utile di $-164.38M, una diminuzione rispetto a agli utili del 2022, che erano di $-62.61M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di HLB Co., Ltd. dal 2012 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2026 (TTM) | $-160.32M | 115.74% |
| 2024 | $-74.31M | -54.79% |
| 2023 | $-164.38M | 162.55% |
| 2022 | $-62.61M | -27.09% |
| 2021 | $-85.87M | 12.36% |
| 2020 | $-76.43M | 43.17% |
| 2019 | $-53.38M | -540.23% |
| 2018 | $12.13M | -138.75% |
| 2017 | $-31.29M | 69.49% |
| 2016 | $-18.46M | -310.93% |
| 2015 | $8.75M | -632.68% |
| 2014 | $-1.64M | -80.80% |
| 2013 | $-8.56M | 40.17% |
| 2012 | $-6.11M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| $5.27B | -3,390.24% |
US
|
|
| $-3.09B | 1,825.53% |
US
|
|
| $-4.02B | 2,405.12% |
AU
|
|
| - | - |
CH
|
|
| $1.95B | -1,316.72% |
NL
|
